Previous 10 | Next 10 |
DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced t...
This article was highlighted for PRO+ subscribers, Seeking Alpha's service for professional investors. Find out how you can get the best content on Seeking Alpha here . With the dust settling from the JP Morgan Healthcare conference in mid-January, a name that is rising above the noise is...
The following slide deck was published by Strongbridge Biopharma plc in conjunction with this Read more ...
Strongbridge Biopharma (NASDAQ: SBBP ) announces preliminary Q4 and full-year 2019 results and provided an update on key corporate priorities for 2020. More news on: Strongbridge Biopharma plc, Healthcare stocks news, Read more ...
~ Expects to Report KEVEYIS ® (dichlorphenamide) Fourth Quarter 2019 Revenue of Approximately $5.6 Million and Full-Year 2019 Revenue of Approximately $21.7 Million, a 29 Percent Increase over 2018 Revenue of $16.8 Million ~ ~ Provides Full-Year 2020 KEVEYIS ® (dichlorphenam...
Just because you escape one trap, doesn't mean you will escape the next .”― Leigh Bardugo It is hard to believe that 2020 is already quickly approaching. Thanks to an uptick in M&A and the rally in the overall market over the past few months, the biotech sector has done ...
The following slide deck was published by Strongbridge Biopharma plc in conjunction with this Read more ...
Strongbridge Biopharma (NASDAQ: SBBP ) is eliminating approx. 15 positions through a reduction in headcount across the organization. More news on: Strongbridge Biopharma plc, Healthcare stocks news, Read more ...
~ The Company Remains Focused on Completing the LOGICS Study and Submitting a New Drug Application (NDA) for RECORLEV™ (levoketoconazole), While Ensuring Continued Growth and Profitability of KEVEYIS® (dichlorphenamide) and Serving the Unmet Needs of the Primary Periodic P...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...
News, Short Squeeze, Breakout and More Instantly...
Strongbridge Biopharma plc Company Name:
SBBP Stock Symbol:
NASDAQ Market:
Strongbridge Biopharma plc Website:
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the "Court") has approved the previously announced proposed a...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “ Company ” or “ Strongbridge ”) today announced that the High Court of Ireland (the “ Court ”) has set the dat...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “ Company ” or “ Strongbridge ”) today announced that its shareholders have voted to approve the previously announced proposed ac...